A wearable cardioverter defibrillator is a lightweight, easy to wear device worn by patients who are at a high risk of a sudden cardiac arrest (SCA). A wearable cardioverter defibrillator is an external device that mainly consist of two components, garment and monitor. The garment is worn under the clothing as a vest to continuously to monitor the heart and on detection of an arrhythmia, it releases a shock to restore heart’s normal rhythm. The monitor is worn around the shoulder using a shoulder strap or around the waist. It records the intensity of the arrhythmia. This whole process happens within a minute, as SCAs are unpredictable and need to be treated via a shock treatment to save victim’s life. A wearable cardioverter defibrillator is an alternative treatment method used to prevent SCAs in non-pacemaker-dependent patients who are awaiting an implant of a cardioverter defibrillator.
According to the World Health Organization (WHO), cardiovascular diseases are a leading cause of mortality globally. These diseases account for 31% of total global mortality. According to the Sudden Cardiac Arrest Association, in the U.S., more than 325,000 people succumb to SCA each year and among those the survival rate is only 10%. According to the European Resuscitation Council, SCAs cause approximately 20% of all deaths in Europe. As per statistical projection of the United Nations (UN), the global number of people over the age of 60 years is projected to increase from 901 million in 2015 to 1.4 billion by 2030.
Cardiac arrest is a public health issue, which has a severe impact on the wellbeing of human health. Prevalence of sudden cardiac arrest is directly proportional to the increasing population, worldwide. Rapid growth in the global geriatric population and rise in the number of sudden cardiac arrest cases are driving the wearable cardioverter defibrillators market. Increasing per capita income of people, rising awareness about cardiac diseases and cardiac arrests are fuelling the wearable cardioverter defibrillators market in developing countries. Technological advancements in wearable cardioverter defibrillator devices, such as reduction in the noise of electrodes, improvements in signal detection, weight and size reduction of the device to make it more comfortable for the patient, is another key factor boosting the wearable cardioverter defibrillators market. However, less awareness about the wearable cardioverter defibrillator device in developing countries and device lacking potential to detect atrial arrhythmia signals are key restrains of the market.
The global wearable cardioverter defibrillators market can be segmented based on application, end-user, and region. In terms of application, the market can be segregated into congenital heart diseases, inherited arrhythmias, and peripartum cardiomyopathy. Based on end-user, the wearable cardioverter defibrillators market can be divided into clinics, hospitals, and home care settings, and others.
In terms of region, the global wearable cardioverter defibrillators market can be categorized into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America accounts for a dominant share in the global wearable cardioverter defibrillators market owing to the increase in awareness among the people regarding sudden cardiac arrests and wearable cardioverter defibrillator devices. Europe constitutes a large share of the market due to technological advancements and rise in the number of cardiac arrest and SCA incidences in the region. The market in Asia Pacific is expanding at a rapid pace owing to the increase in government support, rise in health care expenditure, and surge in per capita income. Increasing demand for wearable cardioverter defibrillator devices in Asia Pacific due to Rise in awareness about these devices, government support, rise in per capita income are some of the factors likely to fuels the market in the region.
Prominent players in the global wearable cardioverter defibrillators market include Medtronic, Cardiac Science, LivaNova, Boston Scientific Corporation, St. Jude Medical LLC, Koninklijke Philips N.V., Nihon Kohden Corporation, Defibtech LLC, and Physio-Control Inc.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.